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Sirs,
Alexander’s disease (AD) is a rare genetic disorder caused
by mutations in the glial fibrillary acid protein (GFAP)
gene characterized by a relentlessly progressive neurolog-
ical decline in children and infants. In contrast, the clinical
course of adult onset forms of AD (AOAD) is usually more
protracted and the clinical presentations vary widely. Here
we present a case of late onset cerebellar ataxia with
marked atrophy of the lower brain stem and the medulla on
magnetic resonance imaging (MRI). Molecular genetic
analysis revealed a novel missense mutation (c.
1148C [ T, p. T383I) in the GFAP gene further broaden-
ing the spectrum of clinical and MRI presentations of
AOAD.
AD is a rare leukodystrophy caused by mutations in the
GFAP gene, typically affecting infants and children [1].
Nearly all AD mutations involve amino acid substitutions,
and a dominant toxic or gain-of-function effect for mutant
GFAP protein was hypothesized [2, 3]. While AD in
infants and children typically presents with psychomotor
retardation, seizures, ataxia and progressive spasticity
leading to death within a few years [1, 2], clinical pheno-
types with AOAD vary considerably and the clinical course
is more protracted [4–6]. MRI criteria have been proposed
for the diagnosis of AD [7]. However, more recent case
series of patients with AOAD involving individuals with
atypical clinical and MRI features not fully meeting the
above diagnostic criteria, suggest that the spectrum of
clinical phenotypes of AOAD may be broader than previ-
ously expected [4–6, 8].
A 65 year old otherwise healthy female of Caucasian
origin presented with a 10 year history of slowly progres-
sive unsteadiness of gait and slurred speech. On neuro-
logical examination, she revealed hypermetric horizontal
saccades. There was moderate cerebellar dysarthria but no
dysphagia or palatal myoclonus. Limb movements were
hypermetric with moderate intention tremor. Reflexes of
the legs were brisk, but plantar responses were flexor and
there were no signs of spasticity. The gait was broad-based,
ataxic. Sensory testing was normal for all modalities. There
was no evidence of cognitive impairment. The family
history revealed that the patient’s father had a tremor and
impaired taste with onset after the age of 70. Both grand-
mothers allegedly suffered from multiple sclerosis. All of
her four children showed no signs of neurological
impairment.
Previous genetic work-up including testing for spinoc-
erebellar ataxia (SCA)-1, -2, -3, -6, -10, and -17 had
revealed no abnormalities. Vitamins E and B12 deficiency
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had been ruled out as well. Enzyme activity of arylsulfatase
A and b-galactocerebrosidase in leukocytes as well as
concentrations of very long chain fatty acids and their
respective ratios were normal. The cerebrospinal fluid
contained 1 cell/ll, and oligoclonal bands were absent.
Axial T2-weighted MR images of the infratentorial
brain region (a, b, c) demonstrate the severe atrophy of the
brain stem, particularly of the medulla oblongata, and
upper spinal cord (b, c, open arrows). Within the atrophic
brain stem linear high T2 signal abnormalities of the cor-
tico-spinal tract can be observed (a, small arrows). In
addition, bilateral abnormalities affecting the hilus of the
dentate nucleus are present (a, large arrows). The sagittal
fluid-attenuated inversion-recovery image (d) shows the
severe atrophy of the medulla oblongata and upper cervical
spinal cord (open arrows) in combination with severe
cerebellar atrophy. Axial T2-weighted images of the
supratentorial regions (e, f) demonstrate bilateral signal
abnormities of the globus pallidus (large arrows). The MRI
findings are shown in Fig. 1.
The nine exons and adjacent intronic regions of the
GFAP gene (NM_002055 and alternative exon eight tran-
script NM_001131019) were PCR amplified (primer
sequences available on request) and directly sequenced. A
missense mutation (c. 1148C [ T, p. T383I; positions
according to RefSeq NM_002055) was detected in exon
seven in heterozygous state. This mutation results in an
amino acid exchange on position 383 from threonine to
isoleucine and a loss of a predicted phosphorylation site
[9]. In silico analysis revealed that this sequence alteration
is ‘‘probably damaging’’ using the polymorphism pheno-
typing tool [9] or ‘‘damaging’’ using the ‘‘sorting intolerant
from tolerant (SIFT)’’ tool [10]. A cohort of 181 ethnically
matched healthy German blood donors was screened for
the mutation by PCR followed by differential enzymatic
restriction with BglII in order to further examine the
functional significance of this mutation. The presence of
the C [ T transition at this position was not detected in any
of the 362 tested control chromosomes.
More than 60 different mutations within the coding
region of GFAP have been identified in association with
AD [1] but only few studies have systematically investi-
gated GFAP mutations in AOAD [4]. The differential
diagnosis of adult onset cerebellar ataxia involves a wide
spectrum of disorders including SCA, autosomal recessive
ataxias such as Friedreich’s ataxia, X-linked cerebellar
ataxias such as ataxia teleangiectasia and fragile X-asso-
ciated tremor/ataxia syndrome (FXTAS), abetalipopro-
teinemia, Refsum disease, late-onset GM2 gangliosidosis,
cerebrotendinous xanthomatosis, autosomal dominant
Fig. 1 MRI findings in a 65 year old woman with a novel missense mutation (c. 1148C [ T, p. T383I) in the GFAP gene. The details are
outlined in the text
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mitochondrial heredoataxias as well as multisystem atro-
phy, vitamin B12 and vitamin E deficiencies, primary
progressive multiple sclerosis and adult manifestations of
leukodystrophies [10–12]. The present case report high-
lights the importance of MR imaging in the differential
diagnosis of adult onset leukodystrophies. Although our
patient met only three out five MRI criteria for AD [7], the
severe atrophy of the medulla oblongata along with signal
abnormalities in the hilus of the dentate nucleus were
suggestive of AOAD [5, 6, 8]. However, the symmetrical
signal abnormalities of the globus pallidus on T2-weighted
images are only rarely seen in AOAD [5, 6, 8].
In accordance with previous reports of AOAD, clinical
progression in our patient was relatively slow compared
with that seen in childhood onset of AD [1, 4–6]. In
summary, sequencing of the GFAP gene should be con-
sidered in cases of late onset cerebellar ataxia, in particular
in the presence of MRI findings compatible with AD. The
spectrum of clinical and MRI phenotypes of AOAD may
still be broader than previously anticipated.
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